Trademark: 79134009
Status Date
Sunday, May 21, 2023
Registration Number
4545774
Registration Date
Tuesday, June 10, 2014
Filing Date
Tuesday, May 21, 2013
Published for Opposition
Tuesday, March 25, 2014
Cancellation Date
Sunday, May 21, 2023
5 Pharmaceutical, veterinary and sanitary products, namely, gene and cell therapy products for the treatment of rare diseases; chemical preparations for medical and pharmaceutical use or for veterinary use, namely, gene and cell therapy products for the treatment of rare diseases; biological preparations for medical and pharmaceutical use or for veterinary use, namely, gene and cell therapy products for the treatment of rare diseases; enzyme preparations for medical and pharmaceutical use or for veterinary use; microorganism cultures for medical and pharmaceutical use or for veterinary use; culture media for bacteriology; nutritive substances for microorganisms for research and development of gene and cell therapy products used in the treatment of rare diseases; preparations of micro-organisms, of genetically modified organisms and of cells for medical and pharmaceutical use or for veterinary use, particularly for gene therapy and cell therapy; compounds acting on genetic or other pathologies, in human beings and animals, particularly on muscle and neuromuscular diseases, diseases of the immune system, cardiovascular diseases, dermatological diseases, diseases of the central and peripheral nervous system, cancers, asthma, allergies, lipid disorders, obesity and diabetes and infectious diseases; kits for preparing cells or for selecting biologically active compounds for medical, biomedical, chemical, genetic, pharmaceutical or veterinary use; diagnostic preparations, reagents and media for medical, biomedical, chemical, genetic, pharmaceutical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; sanitary preparations for medical use
42 Pharmaceutical research; research for the discovery of new medicines; scientific research, particularly in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; basic and applied research in the field of gene and cell therapy; technical research in the field of gene and cell therapy; sorting and selection of molecules for use in gene and cell therapy; development and validation of biological tests, cellular tests and genetic tests; activities in functional genomics for identifying, characterizing, validating or developing biologically active molecules; surveying engineering work; technical project study in the field of gene and cell therapy; professional consultancy unrelated to business operations in the field of scientific research and therapies; research and development of new pharmaceutical products for others
GENETHON BIO PROD
"BIOPROD"
Dec 17, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Dec 17, 2023
Death Of International Registration
Dec 2, 2023
Total Invalidation Processed By The Ib
Nov 14, 2023
Generic Madrid Transaction Sent To Ib
Nov 14, 2023
Generic Madrid Transaction Created
Oct 26, 2021
Total Invalidation Of Reg Ext Protection Created
Feb 26, 2021
Cancelled Section 71
Jun 10, 2019
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Dec 5, 2014
Final Decision Transaction Processed By Ib
Nov 4, 2014
Final Disposition Notice Sent To Ib
Nov 4, 2014
Final Disposition Processed
Sep 10, 2014
Final Disposition Notice Created, To Be Sent To Ib
Jun 10, 2014
Registered-Principal Register
Mar 25, 2014
Official Gazette Publication Confirmation E-Mailed
Mar 25, 2014
Published For Opposition
Mar 21, 2014
Notification Processed By Ib
Mar 5, 2014
Notification Of Possible Opposition Sent To Ib
Mar 5, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 5, 2014
Notification Of Notice Of Publication E-Mailed
Feb 19, 2014
Law Office Publication Review Completed
Feb 19, 2014
Assigned To Lie
Jan 31, 2014
Approved For Pub - Principal Register
Jan 31, 2014
Examiner's Amendment Entered
Jan 31, 2014
Notification Of Examiners Amendment E-Mailed
Jan 31, 2014
Examiners Amendment E-Mailed
Jan 31, 2014
Examiners Amendment -Written
Jan 16, 2014
Teas/Email Correspondence Entered
Jan 16, 2014
Correspondence Received In Law Office
Jan 16, 2014
Teas Response To Office Action Received
Oct 18, 2013
Correction Sent To Ib
Oct 18, 2013
Correction Created For Ib
Oct 8, 2013
Refusal Processed By Ib
Sep 16, 2013
Non-Final Action Mailed - Refusal Sent To Ib
Sep 16, 2013
Refusal Processed By Mpu
Sep 13, 2013
Non-Final Action (Ib Refusal) Prepared For Review
Sep 12, 2013
Non-Final Action Written
Sep 8, 2013
Assigned To Examiner
Aug 16, 2013
Application Filing Receipt Mailed
Aug 12, 2013
New Application Office Supplied Data Entered
Aug 8, 2013
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
